Connecticut Senate Bill SB01039

Connecticut 2017 Regular Session

• Introduced: 3/16/17
• Refer: 3/16/17

Caption

An Act Concerning Criminal Liability In The Case Of Drug Overdose Deaths, Increasing The Penalty For The Possession Of A Narcotic And Criminalizing The Misbranding Of Synthetic Drugs.

Impact

One significant change introduced by SB01039 is the heightened penalty for the possession of narcotic substances, reclassifying such possession as a Class D felony. This shift seeks to deter individuals from engaging in the possession or distribution of narcotics. Furthermore, the bill criminalizes the misbranding of synthetic drugs, establishing a Class D felony for individuals who falsify labels on such substances. This aims to protect public health by ensuring clearer communication of risks associated with synthetic drugs that can closely resemble controlled substances.

Summary

SB01039 aims to address the growing issue of drug overdose deaths by establishing criminal liabilities associated with such fatalities. The bill proposes to classify manslaughter as a crime when an individual's actions lead to another's death due to drug overdose from a controlled substance that was improperly manufactured or distributed. This reclassification into a Class B felony reflects a more stringent approach to discourage irresponsible actions that lead to drug-related deaths and aims to hold individuals accountable for their role in distributing illicit substances.

Contention

This bill has not been without controversy. Proponents argue it is an essential measure in combating the opioid epidemic, highlighting the necessity of holding drug distributors accountable. However, opponents express concern about the implications for public health and criminal justice, arguing that increasing penalties may not effectively address the root cause of addiction and may lead to further stigmatization of individuals seeking help. The debate underscores a significant point of contention regarding how best to balance criminal justice reform with public health initiatives in the realm of substance abuse.